Influenza Vaccination

It's that time of year again, everyone rolling up their sleeves to get a flu shot. This episode dives into the history of the struggles pinning down the causative agent of flu and the journey to the vaccine!

Influenza vaccination was linked to significant decreased risks for major cardiovascular events and death, according to a study published in Scientific Reports.

Influenza activity is increasing in most parts of the United States and is at or above baseline levels in three regions, the CDC reported Monday.

Moderna said Wednesday that its messenger RNA-based combination vaccine against influenza and COVID-19 elicited neutralizing antibody levels that were as high — or higher — than existing vaccines in a phase 1/2 trial.

Influenza poses significant health and socioeconomic threats despite cases drastically dropping during the COVID-19 pandemic.

The CDC recently recommended updated versions of the Moderna and Pfizer-BioNTech COVID-19 vaccines aimed at omicron XBB subvariants of SARS-CoV-2, following their approval by the FDA.

Local influenza spread was associated with temporary increased CV risk, but flu vaccine dose — high or standard — did not prevent hospitalization for cardiopulmonary events or all-cause death in high-risk patients, researchers reported.

August is National Immunization Awareness Month. To mark the occasion, we compiled a list of vaccine stories you may have missed in 2023.

The incidence of stroke, thrombocytopenia and thrombosis were rare in patients following COVID-19 vaccination, while all three complications were more likely in patients who received an influenza vaccination, a report found.

The National Institute of Allergy and Infectious Diseases announced this week that it has started enrolling participants in a phase 1 trial testing an experimental universal influenza vaccine that uses a messenger RNA platform.